BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33194022)

  • 1. Fractalkine mediates lymphocyte inflammation and tubulointerstitial lesions by modifying the Treg/Th17 balance in lupus-prone MRL/lpr mice.
    Fu D; Ma J; Gong Q; Senouthai S; Wang J; You Y; Pinhu L
    Am J Transl Res; 2020; 12(10):6170-6186. PubMed ID: 33194022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of Fractalkine ameliorates renal injury and Treg cell apoptosis via the p38MAPK pathway in lupus-prone mice.
    Ma J; Gong Q; Pan X; Guo P; He L; You Y
    Exp Cell Res; 2021 Aug; 405(2):112704. PubMed ID: 34126056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FKN Facilitates HK-2 Cell EMT and Tubulointerstitial Lesions via the Wnt/β-Catenin Pathway in a Murine Model of Lupus Nephritis.
    Fu D; Senouthai S; Wang J; You Y
    Front Immunol; 2019; 10():784. PubMed ID: 31134047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disabled-2 overexpression mediates immune suppression in systemic lupus erythematosus by modulating Treg/Th17 cell differentiation.
    Zhang J; Chang L; Sun Y; Qin M; Wang X; Guo Y
    Clin Exp Pharmacol Physiol; 2022 May; 49(5):596-607. PubMed ID: 35108421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
    Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
    Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients.
    Chen M; Chen X; Wan Q
    Eur J Clin Invest; 2018 Nov; 48(11):e13012. PubMed ID: 30079446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.
    Fu D; Senouthai S; Wang J; You Y
    BMC Nephrol; 2019 Sep; 20(1):350. PubMed ID: 31488076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD19
    Zhu ZZ; Chen XH; Wei SR; Xu J; Wang YH; Wu WJ; Liu H; Mo HY
    Int J Rheum Dis; 2023 Jun; 26(6):1048-1057. PubMed ID: 37012219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroartemisinin attenuated the symptoms of mice model of systemic lupus erythematosus by restoring the Treg/Th17 balance.
    Chen Y; Tao T; Wang W; Yang B; Cha X
    Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):626-633. PubMed ID: 33469936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs.
    Ji J; Xu J; Zhao S; Liu F; Qi J; Song Y; Ren J; Wang T; Dou H; Hou Y
    Clin Sci (Lond); 2016 Aug; 130(16):1453-67. PubMed ID: 27231253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus.
    Cai Z; Wong CK; Dong J; Jiao D; Chu M; Leung PC; Lau CBS; Lau CP; Tam LS; Lam CWK
    Chin Med; 2016; 11():23. PubMed ID: 27134645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
    Zhang Z; Liu D; Zhang X; Wang X
    Inflammation; 2018 Oct; 41(5):1888-1899. PubMed ID: 29951872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balance.
    Ding M; Jin L; Zhao J; Yang L; Cui S; Wang X; He J; Chang F; Shi M; Ma J; Song S; Jin H; Liu A
    Lupus Sci Med; 2024 Feb; 11(1):. PubMed ID: 38351097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin relieves lupus nephritis by regulating TIM-3 and CD4
    Gao YF; Fan XZ; Li RS; Zhou XS
    Cent Eur J Immunol; 2022; 47(3):206-217. PubMed ID: 36817267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
    Hoseinzadeh A; Rezaieyazdi Z; Mahmoudi M; Tavakol Afshari J; Lavi Arab F; Esmaeili SA; Faridzadeh A; Rezaeian A; Hoseini S; Barati M; Mahmoudi A; Sadat Tabasi N
    Int Immunopharmacol; 2023 Apr; 117():109699. PubMed ID: 36867923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of TIM-3 relieves lupus nephritis by expanding Treg cells and promoting their suppressive capacity in MRL/lpr mice.
    Gao YF; Lu YY; Fan XZ; Wang YH; Tian JH; Saed YA; Li RS; Zhou XS
    Int Immunopharmacol; 2022 Sep; 110():108971. PubMed ID: 35777268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.
    Yang J; Chu Y; Yang X; Gao D; Zhu L; Yang X; Wan L; Li M
    Arthritis Rheum; 2009 May; 60(5):1472-83. PubMed ID: 19404966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.